These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31892803)

  • 1. Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study.
    Protopapas AA; Mylopoulou T; Papadopoulos VP; Vogiatzi K; Goulis I; Mimidis K
    Ann Gastroenterol; 2020; 33(1):87-94. PubMed ID: 31892803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
    Ismail M
    Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria.
    Tan M; Zhang W; Zhou H; Liu Y; Lu T; Zhang Y; Li C; Yang Y; Wu Y; Hu H; Li Y; Yang F; Lin S
    Front Physiol; 2022; 13():1006657. PubMed ID: 36237519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Yan Y; Xing X; Wang X; Yang L
    Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Are We There Yet?
    Silva MJ; Bernardes C; Pinto J; Loureiro R; Duarte P; Mendes M; Calinas F
    GE Port J Gastroenterol; 2017 Mar; 24(2):79-83. PubMed ID: 28848787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
    Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of high-risk esophageal varices in patients with compensated cirrhosis using albumin-bilirubin-platelet score.
    Abd Elbaser ES; Sharaf AL; Farag AA
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):332-337. PubMed ID: 34402476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.